Skip to Content

GSK 12.5 (Paroxetine Extended-Release 12.5 mg)

Pill imprint GSK 12.5 has been identified as Paroxetine hydrochloride extended-release 12.5 mg.

Paroxetine is used in the treatment of anxiety and stress; anxiety; depression; postmenopausal symptoms; obsessive compulsive disorder (and more), and belongs to the drug class selective serotonin reuptake inhibitors. Excluding Brisdelle: There is positive evidence of human fetal risk during pregnancy. Brisdelle: Not for use in pregnancy. Paroxetine 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Paroxetine hydrochloride extended-release 12.5 mg GSK 12.5
Paroxetine hydrochloride extended-release 12.5 mg GSK 12.5
Paroxetine hydrochloride extended-release 12.5 mg GSK 12.5
Paroxetine hydrochloride extended-release
Imprint:
GSK 12.5
Strength:
12.5 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Selective serotonin reuptake inhibitors
Pregnancy Category:
D - Positive evidence of risk - excluding Brisdelle
X - Not for use in pregnancy - Brisdelle
CSA Schedule:
Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-3673
Inactive Ingredients:
hypromelloses
povidone k30
lactose monohydrate
magnesium stearate
silicon dioxide
glyceryl dibehenate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
sodium lauryl sulfate
polysorbate 80
magnesium silicate
triethyl citrate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
60505-3668 Apotex Corp.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide